Arrowstreet Capital, Limited Partnership Iradimed Corp Transaction History

Arrowstreet Capital, Limited Partnership

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$30.15 - $45.79 $517,042 - $785,252	-17,149 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$36.01 - $53.14 $29,564 - $43,627	-821 Reduced 4.57%	17,149 $769,000
Q4 2021 Feb 14, 2022	BUY	$32.35 - $48.27 $581,329 - $867,411	17,970 New	17,970 $830,000
Q4 2018 Feb 14, 2019	SELL	$20.63 - $34.04 $492,726 - $813,011	-23,884 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$20.6 - $37.15 $492,010 - $887,290	23,884 New	23,884 $887,000

138

6.77M

6.9K

100

Ticker IRMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 12,565,100
Market Cap $632M
Description
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible pati...

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.